版本:
中国

BRIEF-Proteon says receives FDA breakthrough therapy designation for vonapanitase

May 10 Proteon Therapeutics Inc

* Proteon therapeutics receives fda breakthrough therapy designation for vonapanitase

* Proteon therapeutics inc- enrollment in patency-2 trial is expected to complete in q1 of 2018

* Proteon therapeutics inc- proteon expects to report top-line data in q1 of 2019

* Proteon therapeutics inc- proteon also expects to submit a bla to fda in 2019.

* Proteon therapeutics inc - proteon also expects to submit a bla to fda in 2019 Source text for Eikon: Further company coverage:

我们的标准: 汤森路透“信任原则

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐